Akèy › Leksemi mieloïd egi › New York › Greenburgh
Etid klinik pou Leksemi mieloïd egi nan Greenburgh, NY
18 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Greenburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Ap rekriteFaz 1
- New York Medical College /ID# 275597, Valhalla · 5 mi lwen
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study of CRD3874-SI in People With Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- New York Medical College, Valhalla · 5 mi lwen
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- New York Medical College, Valhalla · 5 mi lwen
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
A Study of Revumenib and Mezigdomide in People With Leukemia
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Ap rekriteFaz 2
- White Plains Hospital, White Plains · 4 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Seattle, WA41 etid
- Baldwin Park, CA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA31 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan Greenburgh
- Kansè nan tete42 etid
- Kansè Poumon ki pa ti selil28 etid
- Kansè pwostat17 etid
- Kansè (tout kalite)17 etid
- Kansè poumon17 etid
- Myelom Miltip13 etid
- Kansè kolorektal11 etid
- Kansè Metastatik11 etid
- Kansè Endomèt11 etid
- Kansè vejik10 etid
- Limfom9 etid
- Karsinòm selil skuamèz tèt ak kou9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.